Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-((4'-trifluoromethyl-biphenyl-2-carbonyl)-amino)-1h-indole-2-carboxylic Acid Benzylmethyl Carbamoylamide
1. Slentrol
2. 481658-94-0
3. Chembl410414
4. Cp-742,033
5. 578h0rmp25
6. Cp-742033
7. (s)-n-(2-(benzyl(methyl)amino)-2-oxo-1-phenylethyl)-1-methyl-5-(4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamido)-1h-indole-2-carboxamide
8. 1h-indole-2-carboxamide, 1-methyl-n-((1s)-2-(methyl(phenylmethyl)amino)-2-oxo-1-phenylethyl)-5-(((4'-(trifluoromethyl)(1,1'-biphenyl)-2-yl)carbonyl)amino)-
9. N-((1s)-2-(benzylmethylamino)-2-oxo-1-phenylethyl)-1-methyl-5-(((4'-(trifluoromethyl)biphenyl-2-yl)carbonyl)amino)-1h-indole-2-carboxamide
10. Dirlotapide [usan:inn]
11. Unii-578h0rmp25
12. Cp 742033
13. Dirlotapide [mi]
14. Dirlotapide [inn]
15. Dirlotapide (usan/inn)
16. Dirlotapide [usan]
17. Schembl37781
18. Slentrol [veterinary] (tn)
19. Dirlotapide [green Book]
20. Dtxsid00897432
21. Bdbm50204367
22. Hy-u00070
23. Cs-6779
24. Db11399
25. Dirlotapide [ema Epar Veterinary]
26. D03867
27. Q5280905
28. (s)-n-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1h-indole-2-carboxamide
29. 5-((4'-trifluoromethyl-biphenyl-2-carbonyl)-amino)-1h-indole-2-carboxylic Acid Benzylmethyl Carbamoylamide
30. N-[(1s)-2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]-1-methyl-5-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]indole-2-carboxamide
| Molecular Weight | 674.7 g/mol |
|---|---|
| Molecular Formula | C40H33F3N4O3 |
| XLogP3 | 7.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 674.25047541 g/mol |
| Monoisotopic Mass | 674.25047541 g/mol |
| Topological Polar Surface Area | 83.4 Ų |
| Heavy Atom Count | 50 |
| Formal Charge | 0 |
| Complexity | 1150 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.
QA08AB91
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
91
PharmaCompass offers a list of Dirlotapide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dirlotapide manufacturer or Dirlotapide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dirlotapide manufacturer or Dirlotapide supplier.
PharmaCompass also assists you with knowing the Dirlotapide API Price utilized in the formulation of products. Dirlotapide API Price is not always fixed or binding as the Dirlotapide Price is obtained through a variety of data sources. The Dirlotapide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dirlotapide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dirlotapide, including repackagers and relabelers. The FDA regulates Dirlotapide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dirlotapide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dirlotapide supplier is an individual or a company that provides Dirlotapide active pharmaceutical ingredient (API) or Dirlotapide finished formulations upon request. The Dirlotapide suppliers may include Dirlotapide API manufacturers, exporters, distributors and traders.
Dirlotapide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dirlotapide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dirlotapide GMP manufacturer or Dirlotapide GMP API supplier for your needs.
A Dirlotapide CoA (Certificate of Analysis) is a formal document that attests to Dirlotapide's compliance with Dirlotapide specifications and serves as a tool for batch-level quality control.
Dirlotapide CoA mostly includes findings from lab analyses of a specific batch. For each Dirlotapide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dirlotapide may be tested according to a variety of international standards, such as European Pharmacopoeia (Dirlotapide EP), Dirlotapide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dirlotapide USP).
